{"url":"https://lda.senate.gov/api/v1/filings/c77788ae-70d1-4b3d-970e-df66c19ca636/","filing_uuid":"c77788ae-70d1-4b3d-970e-df66c19ca636","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2022,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c77788ae-70d1-4b3d-970e-df66c19ca636/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Lisa Nelson","dt_posted":"2023-01-20T14:28:39-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"160 Federal Street","registrant_address_2":"21st floor","registrant_different_address":false,"registrant_city":"Boston","registrant_state":"MA","registrant_zip":"02110","registrant":{"id":401106521,"url":"https://lda.senate.gov/api/v1/registrants/401106521/","house_registrant_id":45568,"name":"AMRYT PHARMA","description":null,"address_1":"160 Federal Street","address_2":"21st floor","address_3":null,"address_4":null,"city":"Boston","state":"MA","state_display":"Massachusetts","zip":"02110","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LISA NELSON","contact_telephone":"+1 301-873-1498","dt_updated":"2023-08-30T14:25:19.529320-04:00"},"client":{"id":51863,"url":"https://lda.senate.gov/api/v1/clients/51863/","client_id":51863,"name":"AMRYT PHARMA","general_description":"pharmaceutical company","client_government_entity":null,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-06-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to rare disease innovation including the HEART ACT (HR 7667) and the BENEFIT Act (HR4472).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139640,"prefix":"mrs","prefix_display":"MRS.","first_name":"LISA","nickname":null,"middle_name":"F","last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}